Showing results (21-30 of 28) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Journal of Cardiovascular Electrophysiology|April 29, 2025
Genome-Wide Association Study of Atrial Fibrillation Recurrence After Radiofrequency Catheter Ablation in a Japanese PopulationTakumi Sakai, Motoki Furutani, Mika Nakashima, et al.Journal of Thrombosis and Thrombolysis|October 5, 2025
RNA sequence analysis of differentially expressed genes in left atrial appendage thrombusJunji Maeda, Motoki Furutani, Shunsuke Miyauchi, et al.Heart Rhythm|July 20, 2026
Genome-Wide Identification of a MINK1 Variant Associated with Asymptomatic Paroxysmal Atrial FibrillationSho Okamura, Motoki Furutani, Mika Nakashima, et al.JACC. Advances|May 29, 2026
Genetic Variants Associated With Nonpulmonary Vein Triggers of Atrial Fibrillation: A Genome-Wide Association StudySho Okamura, Motoki Furutani, Mika Nakashima, et al.Cancer Chemotherapy and Pharmacology|September 23, 2020
A placebo-controlled, double-blind, randomized study of recombinant thrombomodulin (ART-123) to prevent oxaliplatin-induced peripheral neuropathyMasahito Kotaka, Yoji Saito, Takeshi Kato, et al.Journal of the American Heart Association|June 9, 2026
Genetic Investigation of Corrected QT Interval Sensitivity to Oral Bepridil Hydrochloride Hydrate in Patients With Atrial FibrillationNaoki Ishibashi, Motoki Furutani, Mika Nakashima, et al.Molecular Cancer Therapeutics|November 6, 2009
Small-molecule inhibition of Wee1 kinase by MK-1775 selectively sensitizes p53-deficient tumor cells to DNA-damaging agentsHiroshi Hirai, Yoshikazu Iwasawa, Megumu Okada, et al.JAMA|May 20, 2019
Effect of a Recombinant Human Soluble Thrombomodulin on Mortality in Patients With Sepsis-Associated Coagulopathy: The SCARLET Randomized Clinical TrialJean-Louis Vincent, Bruno Francois, Igor Zabolotskikh, et al.Pageof 3